Long Term Safety of Drugs in Systemic Juvenile Idiopathic Arthritis

被引：0
|
作者：
Gimenez, Ana Isabel Rebollo [1 ]
Carlini, Luca [2 ]
Miettunen, Paivi [3 ,4 ]
Alexeeva, Ekaterina [5 ]
Myrup, Charlotte [6 ]
Nicolai, Rebecca [7 ]
Trachana, Maria [8 ]
Stenevicha, Valda [9 ]
Ailioaie, Constantin [10 ]
Tsitsami, Elena [11 ]
Cochino, Alexis-Virgil [12 ]
Pallotti, Chiara [13 ]
Scala, Silvia [13 ]
Pistorio, Angela [14 ]
Vastert, Sebastiaan [15 ]
Swart, Joost [16 ]
Ruperto, Nicolino [17 ]
机构：
[1] IRCCS Ist Giannina Gaslini, UOC Reumatol & Malattie Autoinfiammatorie, Genoa, Italy
[2] Ist Giannina Gaslini, UOC Serv Sperimentazioni Clin Pediat, PRINTO, Genoa, Italy
[3] Univ Calgary, Calgary, AB, Canada
[4] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada
[5] Sechenov First Moscow State Med Univ, Minist Hlth Russian Federat, Moscow, Russia
[6] Rigshosp, Pediat Rheumatol Unit 4272, Copenhagen, Denmark
[7] IRCCS Osped Pediat Bambino Gesu, Div Rheumatol, Rome, Italy
[8] Thessaloniki Univ, Hippokrat Gen Hosp, Pediat Immunol & Rheumatol Referral Ctrv, Dept Pediat 1,Sch Med, Thessaloniki, Greece
[9] Riga Stradins Univ, Children Univ Hosp, Dept Paediat, Riga, Latvia
[10] Alexandru Ioan Cuza Univ, Pediat Rheumatol, Iasi, Romania
[11] Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Pediat Rheumatol Unit, Athens, Greece
[12] Univ Athens Med Sch, Aghia Sophia Childrens Hosp, Dept Pediat, Athens, Greece
[13] IRCCS Ist Giannina Gaslini, Pediat & Rheumatol Clin, Genoa, Italy
[14] IRCCS Ist Giannina Gaslini, Direzione Sci, Genoa, Italy
[15] Univ Med Ctr Utrecht, Utrecht, Netherlands
[16] UMC Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands
[17] Ist Giannina Gaslini, UOSID Ctr Trial, Genoa, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0355
引用
收藏
页码：697 / 698
页数：2
相关论文
共 50 条
  • [31] SAFETY PROFILE OF ETANERCEPT IN LONG-TERM USE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Klotsche, Jens
    Klein, Ariane
    Niewerth, Martina
    Ganser, Gerd
    Aries, Peer
    Walther, Marisa
    Haas, Peter
    Keysser, Gernot
    Horneff, Gerd
    Minden, Kirsten
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 102 - 102
  • [32] Therapy Survival and Long-Term Safety of Etanercept in Patients with juvenile idiopathic Arthritis (JIA)
    Klotsche, J.
    Niewerth, M.
    Weber, K.
    Hammer, M.
    Haas, J.
    Horneff, G.
    Minden, K.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 92 - 93
  • [33] A safety evaluation of canakinumab for the treatment of systemic onset juvenile idiopathic arthritis
    Wulffraat, Nico M.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1961 - 1967
  • [34] Efficacy and Safety of Tocilizumab in Patients with Severe Systemic Juvenile Idiopathic Arthritis
    Alekseeva, Ekaterina I.
    Denisova, Rina V.
    Valieva, Saniya I.
    Bsarova, Tatyana M.
    Isaeva, Kseniya B.
    Chistyakova, Evgeniya G.
    Sleptsova, Tatyana V.
    Mitenko, Elena V.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2011, 1 (04) : 190 - 198
  • [35] Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (06) : 387 - 397
  • [36] EFFICACY AND SAFETY OF RITUXIMAB RETREATMENT IN REFRACTORY SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
    Alexeeva, E.
    Valiyeva, S.
    Denisova, R.
    Bzarova, T.
    Isayeva, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 428 - 428
  • [37] Efficacy and safety of abatacept for systemic juvenile idiopathic arthritis: A systematic review
    Nishimura, Kenichi
    Ishikawa, Takashi
    Okamoto, Nami
    Akamine, Keiji
    Inoue, Natsumi
    Irabu, Hitoshi
    Kato, Kentaro
    Keino, Hiroshi
    Kojima, Masayo
    Kubo, Hiroshi
    Maruyama, Kazuichi
    Mizuta, Mao
    Shabana, Kosuke
    Shimizu, Masaki
    Sugita, Yuko
    Takakuwa, Yukiko
    Takanashi, Satoshi
    Takase, Hiroshi
    Umebayashi, Hiroaki
    Umezawa, Natsuka
    Yamanishi, Shingo
    Yamazaki, Kazuko
    Yashiro, Masato
    Yasumi, Takahiro
    Mori, Masaaki
    MODERN RHEUMATOLOGY, 2024, 35 (01) : 167 - 173
  • [38] Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III
    Brunner, Hermine
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Vritzali, Eleni
    Lheritier, Karine
    Martini, Alberto
    Lovell, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 64 - 66
  • [39] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A SINGLE-CENTER STUDY
    Alexeeva, E.
    Krekhova, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Chomakhidze, A.
    Chistyakova, E.
    Lomakina, O.
    Denisova, R.
    Mamutova, A.
    Fetisova, A.
    Gautier, M.
    Vankova, D.
    Shingarova, M.
    Kriulin, I.
    Alshevskaya, A.
    Moskalev, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1776 - 1777
  • [40] CARDIOVASCULAR RISK IN LONG-TERM JUVENILE IDIOPATHIC ARTHRITIS
    Aranda-Valera, I.
    Arias de la Rosa, I.
    Roldan Molina, R.
    Abalos-Aguilera, C.
    Perez-Sanchez, C.
    Escudero, A.
    Lopez-Pedrera, R.
    Collantes-Estevez, E.
    Barbarroja, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 489 - 489
12345